PL375254A1 - PEG-ilowany polipeptyd T20 - Google Patents
PEG-ilowany polipeptyd T20Info
- Publication number
- PL375254A1 PL375254A1 PL03375254A PL37525403A PL375254A1 PL 375254 A1 PL375254 A1 PL 375254A1 PL 03375254 A PL03375254 A PL 03375254A PL 37525403 A PL37525403 A PL 37525403A PL 375254 A1 PL375254 A1 PL 375254A1
- Authority
- PL
- Poland
- Prior art keywords
- pegylated
- polypeptide
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39819502P | 2002-07-24 | 2002-07-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL375254A1 true PL375254A1 (pl) | 2005-11-28 |
Family
ID=31495720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03375254A PL375254A1 (pl) | 2002-07-24 | 2003-07-16 | PEG-ilowany polipeptyd T20 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7049415B2 (pl) |
| EP (1) | EP1527088B1 (pl) |
| JP (1) | JP4381301B2 (pl) |
| KR (1) | KR100637981B1 (pl) |
| CN (1) | CN100357317C (pl) |
| AR (1) | AR040651A1 (pl) |
| AT (1) | ATE489401T1 (pl) |
| AU (1) | AU2003257467B2 (pl) |
| BR (1) | BR0312889A (pl) |
| CA (1) | CA2493534C (pl) |
| DE (1) | DE60335111D1 (pl) |
| ES (1) | ES2354609T3 (pl) |
| GT (1) | GT200300155A (pl) |
| HR (1) | HRP20050024A2 (pl) |
| IL (2) | IL166038A0 (pl) |
| MX (1) | MXPA05000797A (pl) |
| NO (1) | NO20050066L (pl) |
| PA (1) | PA8577701A1 (pl) |
| PE (1) | PE20040705A1 (pl) |
| PL (1) | PL375254A1 (pl) |
| RU (1) | RU2296769C2 (pl) |
| TW (1) | TW200416225A (pl) |
| WO (1) | WO2004013164A1 (pl) |
| ZA (1) | ZA200500258B (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6057287A (en) | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| PT2298278E (pt) | 2002-06-07 | 2016-02-25 | Dyax Corp | Prevenção e redução da perda de sangue e resposta inflamatória |
| US7153829B2 (en) | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
| CA3050564A1 (en) * | 2003-08-29 | 2005-03-10 | Dyax Corp. | Poly-pegylated protease inhibitors |
| CA2537113A1 (en) * | 2003-08-29 | 2005-03-10 | Dyax Corp. | Modified protease inhibitors |
| EP1725262B1 (en) * | 2004-03-15 | 2021-05-26 | Nektar Therapeutics | Polymer-based compositions and conjugates of hiv entry inhibitors |
| US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
| BRPI0609555A2 (pt) * | 2005-04-08 | 2010-04-13 | Lonza Ag | sìntese de peptìdeo de alfa-espirais sobre resina peg |
| WO2009026334A2 (en) * | 2007-08-21 | 2009-02-26 | Genzyme Corporation | Treatment with kallikrein inhibitors |
| JP2013516389A (ja) | 2009-01-06 | 2013-05-13 | ダイアックス コーポレーション | カリクレイン阻害剤による粘膜炎治療 |
| ES2905545T3 (es) | 2010-01-06 | 2022-04-11 | Takeda Pharmaceuticals Co | Proteínas de unión a calicreína plasmática |
| KR102011156B1 (ko) | 2011-01-06 | 2019-08-16 | 다이액스 코포레이션 | 혈장 칼리크레인 결합 단백질 |
| IL247942B (en) | 2014-03-27 | 2022-09-01 | Dyax Corp | Compositions and methods for drops in macular edema as a result of diabetes |
| US20160151511A1 (en) | 2014-12-02 | 2016-06-02 | Antriabio, Inc. | Proteins and protein conjugates with increased hydrophobicity |
| US11286307B2 (en) | 2015-12-11 | 2022-03-29 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack |
| AU2021209045A1 (en) | 2020-01-13 | 2022-07-28 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US153694A (en) * | 1874-08-04 | Improvement in clothes-pounders | ||
| KR850004274A (ko) * | 1983-12-13 | 1985-07-11 | 원본미기재 | 에리트로포이에틴의 제조방법 |
| US5252714A (en) * | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
| US5464933A (en) * | 1993-06-07 | 1995-11-07 | Duke University | Synthetic peptide inhibitors of HIV transmission |
| US5795569A (en) * | 1994-03-31 | 1998-08-18 | Amgen Inc. | Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation |
| CH690143A5 (de) * | 1995-01-27 | 2000-05-15 | Rieter Automotive Int Ag | Lambda/4-Schallabsorber. |
| US5672662A (en) * | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
| US5990237A (en) * | 1997-05-21 | 1999-11-23 | Shearwater Polymers, Inc. | Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines |
| US6281331B1 (en) * | 1998-03-23 | 2001-08-28 | Trimeris, Inc. | Methods and compositions for peptide synthesis |
| NZ507083A (en) * | 1998-03-23 | 2003-10-31 | Trimeris Inc | Methods and compositions for peptide synthesis, in particular T-20 (DP-178) and T-20-like peptides |
| WO2000024697A1 (en) | 1998-10-26 | 2000-05-04 | University Of Utah Research Foundation | Method for preparation of polyethylene glycol aldehyde derivatives |
| JP2002531089A (ja) * | 1998-11-30 | 2002-09-24 | イーライ・リリー・アンド・カンパニー | 赤血球産生性化合物 |
| PE20010288A1 (es) * | 1999-07-02 | 2001-03-07 | Hoffmann La Roche | Derivados de eritropoyetina |
| RU2179980C2 (ru) * | 2000-03-20 | 2002-02-27 | Государственный научный центр вирусологии и биотехнологии "Вектор" | Пептид-имитатор консервативного эпитопа белка gp41 вируса иммунодефицита человека типа 1, узнаваемого вируснейтрализующими моноклональными антителами 2f5 (варианты) |
| KR100488351B1 (ko) * | 2001-12-11 | 2005-05-11 | 선바이오(주) | 신규한 폴리에틸렌글리콜-프로피온알데히드 유도체 |
-
2003
- 2003-07-16 BR BR0312889-0A patent/BR0312889A/pt not_active IP Right Cessation
- 2003-07-16 PL PL03375254A patent/PL375254A1/pl not_active Application Discontinuation
- 2003-07-16 EP EP03766190A patent/EP1527088B1/en not_active Expired - Lifetime
- 2003-07-16 WO PCT/EP2003/007710 patent/WO2004013164A1/en not_active Ceased
- 2003-07-16 JP JP2004525219A patent/JP4381301B2/ja not_active Expired - Fee Related
- 2003-07-16 CA CA2493534A patent/CA2493534C/en not_active Expired - Fee Related
- 2003-07-16 KR KR1020057001217A patent/KR100637981B1/ko not_active Expired - Fee Related
- 2003-07-16 DE DE60335111T patent/DE60335111D1/de not_active Expired - Lifetime
- 2003-07-16 AU AU2003257467A patent/AU2003257467B2/en not_active Ceased
- 2003-07-16 IL IL16603803A patent/IL166038A0/xx unknown
- 2003-07-16 CN CNB038176807A patent/CN100357317C/zh not_active Expired - Fee Related
- 2003-07-16 HR HR20050024A patent/HRP20050024A2/xx not_active Application Discontinuation
- 2003-07-16 MX MXPA05000797A patent/MXPA05000797A/es active IP Right Grant
- 2003-07-16 RU RU2005105577/04A patent/RU2296769C2/ru not_active IP Right Cessation
- 2003-07-16 AT AT03766190T patent/ATE489401T1/de active
- 2003-07-16 ES ES03766190T patent/ES2354609T3/es not_active Expired - Lifetime
- 2003-07-18 TW TW092119716A patent/TW200416225A/zh unknown
- 2003-07-21 US US10/623,873 patent/US7049415B2/en not_active Expired - Fee Related
- 2003-07-21 PA PA20038577701A patent/PA8577701A1/es unknown
- 2003-07-22 PE PE2003000729A patent/PE20040705A1/es not_active Application Discontinuation
- 2003-07-22 AR AR20030102621A patent/AR040651A1/es unknown
- 2003-07-23 GT GT200300155A patent/GT200300155A/es unknown
-
2004
- 2004-12-29 IL IL166038A patent/IL166038A/en not_active IP Right Cessation
-
2005
- 2005-01-06 NO NO20050066A patent/NO20050066L/no not_active Application Discontinuation
- 2005-01-11 ZA ZA2005/00258A patent/ZA200500258B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20050066L (no) | 2005-04-22 |
| BR0312889A (pt) | 2005-06-14 |
| PE20040705A1 (es) | 2004-10-14 |
| HRP20050024A2 (en) | 2006-02-28 |
| RU2296769C2 (ru) | 2007-04-10 |
| JP2006511455A (ja) | 2006-04-06 |
| EP1527088B1 (en) | 2010-11-24 |
| PA8577701A1 (es) | 2004-02-07 |
| AU2003257467A1 (en) | 2004-02-23 |
| RU2005105577A (ru) | 2005-10-27 |
| CA2493534C (en) | 2010-01-26 |
| WO2004013164A1 (en) | 2004-02-12 |
| KR20050027257A (ko) | 2005-03-18 |
| US7049415B2 (en) | 2006-05-23 |
| GT200300155A (es) | 2004-03-15 |
| ES2354609T3 (es) | 2011-03-16 |
| KR100637981B1 (ko) | 2006-10-23 |
| US20040049018A1 (en) | 2004-03-11 |
| DE60335111D1 (de) | 2011-01-05 |
| CA2493534A1 (en) | 2004-02-12 |
| JP4381301B2 (ja) | 2009-12-09 |
| CN100357317C (zh) | 2007-12-26 |
| AU2003257467B2 (en) | 2008-02-28 |
| IL166038A (en) | 2010-11-30 |
| TW200416225A (en) | 2004-09-01 |
| CN1671736A (zh) | 2005-09-21 |
| AR040651A1 (es) | 2005-04-13 |
| ZA200500258B (en) | 2006-01-25 |
| EP1527088A1 (en) | 2005-05-04 |
| ATE489401T1 (de) | 2010-12-15 |
| MXPA05000797A (es) | 2005-04-19 |
| IL166038A0 (en) | 2006-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL166038A0 (en) | Pegylated t20 polypeptide | |
| AU2002367859A8 (en) | Polypeptide immobilization | |
| AU2003290563A8 (en) | Leptin-related peptides | |
| PL375218A1 (pl) | Zrekombinowane warianty białka | |
| GB0201679D0 (en) | Polypeptide variants | |
| GB0100196D0 (en) | Peptides | |
| EP1614695A4 (en) | POLYPEPTIDE | |
| GB0218977D0 (en) | Polypeptide | |
| GB0109438D0 (en) | Peptides | |
| IL166037A0 (en) | Pegylated t1249 polypeptide | |
| GB0223193D0 (en) | Polypeptide | |
| GB0202275D0 (en) | Peptide | |
| GB0103517D0 (en) | Polypeptide | |
| GB0208925D0 (en) | Polypeptide | |
| GB0219980D0 (en) | Peptides | |
| EP1477559A4 (en) | NEW POLYPEPTIDE | |
| GB0210746D0 (en) | Peptide | |
| GB0202221D0 (en) | Novel polypeptide | |
| GB0101739D0 (en) | Novel polypeptide | |
| GB0222181D0 (en) | Polypeptide | |
| GB0219720D0 (en) | Polypeptide | |
| GB0213246D0 (en) | Peptides | |
| GB0224896D0 (en) | Peptides | |
| GB0101222D0 (en) | Novel polypeptide | |
| GB0100039D0 (en) | Novel polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |